Assuming parkinson's is required, the following results were found.

  • Living near major roads linked to risk of dementia, Parkinson's, Alzheimer's and MS - YubaNet

    January 24, 2020 – Living near major roads or highways is linked to higher incidence of dementia, Parkinson’s disease, Alzheimer’s disease and multiple sclerosis (MS), suggests new research published this week in the journal Environmental Health....

    https://mschristian.org/index.php/blog/living-near-major-roads-linked-to-risk-of-dementia-parkinson-s-alzheimer-s-and-ms-yubanet
  • First-in-kind Human 3-dimensional Models of Parkinson's Disease and Progressive Multiple Sclerosis Launching to the International Space Station - Business Wire

    LOUISVILLE, Ky.--(BUSINESS WIRE)--The National Stem Cell Foundation (NSCF) announced today that research teams from Aspen Neuroscience and the New York Stem Cell Foundation (NYSCF) Research Institute will send a first-in-kind study of neurodegenerative...

    https://mschristian.org/index.php/blog/first-in-kind-human-3-dimensional-models-of-parkinson-s-disease-and-progressive-multiple-sclerosis-launching-to-the-international-space-station-business-wire
  • New insights into how immune system and inflammation play a role in PD

    by Kate Anderton, B.Sc. (Editor)Nov 14 2019 Relatively new research findings indicating that the earliest stages of Parkinson's disease (PD) may occur in the gut have been gaining traction in recent years. In a review published in the Journal of...

    https://mschristian.org/index.php/blog/new-insights-into-how-immune-system-and-inflammation-play-a-role-in-pd
  • Rethinking neurodegenerative disease treatment: Target multiple pathological proteins

    Nearly all major neurodegenerative diseases -- from Alzheimer's to Parkinson's -- are defined and diagnosed by the presence of one of four proteins that have gone rogue: tau, amyloid-beta (Aβ), alpha-synuclein (α-syn), or TDP-43. As such,...

    https://mschristian.org/index.php/blog/rethinking-neurodegenerative-disease-treatment-target-multiple-pathological-proteins
  • Alzheimer’s Vaccine; Parkinson's PET Tracer; Fitness and Cognition

    (Alzheimer's Research & Therapy; PhillyVoice) Targeting the messenger RNA that encodes alpha synuclein may slow down Parkinson's disease progression. (PNAS) The FDA approved Fluorodopa F18, a PET tracer to help see damaged or lost nerve cells in people...

    https://mschristian.org/index.php/blog/alzheimer-s-vaccine-parkinson-s-pet-tracer-fitness-and-cognition
  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    (a potential remyelination therapyin MS), BIIB074/vixotrigine (trigeminal neuralgia and small fiber neuropathy), BIIB054 (Parkinson's), BG11/STX-100 (idiopathic pulmonary fibrosis or IPF), dapirolizumab pegol (active systemic lupus erythematosus [SLE],...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Novel PET imaging agent could help guide therapy for brain diseases

    agent that could help guide and assess treatments for people with various neurological diseases, including Alzheimer's, Parkinson's, and multiple sclerosis. The agent targets receptors in nerve cells in the brain that are involved in learning and...

    https://mschristian.org/index.php/blog/novel-pet-imaging-agent-could-help-guide-therapy-for-brain-diseases
  • Senior Planner - Chico Enterprise-Record

    Senior Planner CARD Senior Programs (call regarding cost and dates): Lakeside Pavilion: 2565 California Park Drive, Chico, 895-4015. CARD Community Center: 545 Vallombrosa Ave., Chico, 895-4711. Pleasant Valley Recreation Center (PV): 2320 North Ave.,...

    https://mschristian.org/index.php/blog/senior-planner-chico-enterprise-record-1
  • Repurposed Mucolytic Shows Promise for Neuroprotection in Parkinson's Disease

    (MedPage Today) -- Study Authors: Stephen Mullin, Laura Smith, et al.Target Audience and Goal Statement: Neurologists, radiologists, neuropsychologists, pulmonologists, family physiciansThe goal of this study was to assess the safety, tolerability......

    https://mschristian.org/index.php/blog/repurposed-mucolytic-shows-promise-for-neuroprotection-in-parkinson-s-disease
  • First evidence of immune response targeting brain cells in autism - Medical Xpress

    in brain diseases, such as the tangles and plaques that characterize Alzheimer's disease and the Lewy bodies seen in Parkinson's. Until now, we have not had a promising target like that in autism." Anderson was examining brains donated to Autism...

    https://mschristian.org/index.php/blog/first-evidence-of-immune-response-targeting-brain-cells-in-autism-medical-xpress
  • Vitamin D no defense against dementia

    that vitamin D (also commonly known as the sunshine vitamin) is unlikely to protect individuals from multiple sclerosis, Parkinson's disease, Alzheimer's disease or other brain-related disorders. The findings, released today in the science journal...

    https://mschristian.org/index.php/blog/vitamin-d-no-defense-against-dementia
  • Music Therapy for MS: How Rhythm Can Help With Movement and Memory

    Music and rhythm can improve the brain’s ability to function and the body’s ability to move. By David Spero, RN Medically Reviewed by Samuel Mackenzie, MD, PhD Have you found yourself clumsier or less coordinated since you developed multiple sclerosis...

    https://mschristian.org/index.php/blog/music-therapy-for-ms-how-rhythm-can-help-with-movement-and-memory
  • Could medical marijuana help older people with their ailments?

    have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral sclerosis, Parkinson's disease, neuropathy, spinal cord damage and multiple sclerosis, according to a preliminary study released today that will...

    https://mschristian.org/index.php/blog/could-medical-marijuana-help-older-people-with-their-ailments
  • AAN recommends people 65+ be screened yearly for memory problems

    prevalent with older age. The measure complements past American Academy of Neurology quality measures released for Parkinson's disease, multiple sclerosis and stroke,and allows for a doctor to meet the measure with a recommended periodic three-minute...

    https://mschristian.org/index.php/blog/aan-recommends-people-65-be-screened-yearly-for-memory-problems
  • Researchers Discover Molecular Switch That Repairs Neurological Damage - Interesting Engineering

    Curing disorders such as multiple sclerosis could one day be as simple as turning on a molecular switch thanks to new research by Isobel Scarisbrick, Ph.D., published in the Journal of Neuroscience. Her work finds that by genetically switching off a...

    https://mschristian.org/index.php/blog/researchers-discover-molecular-switch-that-repairs-neurological-damage-interesting-engineering
  • NMSS updates - Key MS Policy Priorities Funded for FY 2020

    On December 20, 2019, the President signed funding bills passed by Congress earlier this week. These funding bills provide the funding for the remainder of Fiscal Year (FY) 2020. MS Activists' work throughout the year resulted in significant increases...

    https://mschristian.org/index.php/blog/nmss-updates-key-ms-policy-priorities-funded-for-fy-2020
  • Dementia Life Expectancy; Teens and Opioids; Duchenne Test for Newborns

    expectancy after dementia diagnosis to help guide care planning. (Neurology) The levodopa paradox: why don't untreated Parkinson's patients have the "ineffective stepping" type of freezing? (JAMA Neurology) Mice watching the opening scene of the Orson...

    https://mschristian.org/index.php/blog/dementia-life-expectancy-teens-and-opioids-duchenne-test-for-newborns
  • AJMC® in the Press, September 13, 2019 - AJMC.com Managed Markets Network

    Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press. A study published in this month’s issue ofThe American Journal of Managed Care®(AJMC®) evaluated the patterns of clinical service for long-term nursing...

    https://mschristian.org/index.php/blog/ajmc-in-the-press-september-13-2019-ajmc-com-managed-markets-network
  • CareCentrix Releases New Series of #CareTalk Podcasts and Videos Shot Live at HLTH - P&T Community

    HARTFORD, Conn., Nov. 7, 2019 /PRNewswire/ -- Today, CareCentrix, the leading provider of home-based, post-acute care solutions, released new episodes of their popular video and podcast series #CareTalk, that were shot live at HLTH, the industry's...

    https://mschristian.org/index.php/blog/carecentrix-releases-new-series-of-caretalk-podcasts-and-videos-shot-live-at-hlth-p-t-community
  • Why do people get MS?

    The best simple answer is "bad luck." A more complete explanation is that why an individual develops MS is due to a combination of factors which elevated risk. In the US, about 1 in 250 people will develop MS. Most of the risk of getting MS has to do...

    https://mschristian.org/index.php/articles/ms-and-demyelinating-diseases/12-why-do-people-get-ms

Results 1 - 20 of 28
 
 

Follow Us on Twitter

Follow Us On Twitter - Image